Infinity Pharmaceuticals Inc (INFIQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,001 | -11,045 | -44,369 | -35,139 | -24,422 |
| Depreciation Amortization | 211 | 105 | 458 | 352 | 241 |
| Accounts payable and accrued liabilities | N/A | N/A | -300 | N/A | N/A |
| Other Working Capital | -1,598 | -2,848 | -1,039 | -484 | -1,079 |
| Other Operating Activity | 1,805 | 1,212 | 2,819 | 1,740 | 1,130 |
| Operating Cash Flow | $-20,583 | $-12,576 | $-42,431 | $-33,531 | $-24,130 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | -38 | -38 | -10,769 |
| PPE Investments | N/A | N/A | -17 | -17 | -17 |
| Investing Cash Flow | $N/A | $N/A | $-55 | $-55 | $-10,786 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 16 | N/A | 73 | 42 | 28 |
| Financing Cash Flow | $16 | $N/A | $73 | $42 | $28 |
| Beginning Cash Position | 38,471 | 38,471 | 80,884 | 80,884 | 80,884 |
| End Cash Position | 17,904 | 25,895 | 38,471 | 47,340 | 45,996 |
| Net Cash Flow | $-20,567 | $-12,576 | $-42,413 | $-33,544 | $-34,888 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,583 | -12,576 | -42,431 | -33,531 | -24,130 |
| Capital Expenditure | N/A | N/A | -17 | -17 | -17 |
| Free Cash Flow | -20,583 | -12,576 | -42,448 | -33,548 | -24,147 |